NCT06850415

Brief Summary

The goal of this clinical trial is to learn if the local made colonic transit capsule can be use to diagnose slow transit constipation. The main questions it aims to answer are:

  • Does the local made colonic transit capsule correlate with the standard colonic capsule in the diagnosis of slow transit constipation?
  • Does the number of remained radiopaque marker similar between the two test after five days of ingestion? Researchers will compare the local made colonic capsule with the standard Sitzmark colonic capsule to see the correlation. Participants will:
  • Take both local made colonic capsule and Sitzmark colonic capsule at the same time.
  • Obtain abdominal x-ray 5 days after capsule ingestion.
  • Keep a diary of their symptoms and medication used during investigation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 19, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 27, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

March 30, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2025

Completed
Last Updated

September 30, 2025

Status Verified

September 1, 2025

Enrollment Period

2 months

First QC Date

February 19, 2025

Last Update Submit

September 27, 2025

Conditions

Keywords

Chronic constipationSlow transit constipationColonic transitColonic transit capsuleRadiopaque markerDiagnostic accuracy

Outcome Measures

Primary Outcomes (2)

  • Correlation in the number of retained radiopaque markers from abdominal x-ray

    The correlation in the number of retained radiopaque markers in abdominal x-ray between Sitzmark colonic capsule and Siriraj gastrointestinal transit capsule.

    5 days after intervention

  • Correlation in the diagnosis of slow transit constipation with radiopaque marker method

    The correlation in the diagnosis of slow transit constipation between Sitzmark colonic capsule and Siriraj gastrointestinal transit capsule defined as retained 20% or more of radiopaque marker in abdominal x-ray after 5 days of ingestion.

    5 days after intervention

Secondary Outcomes (1)

  • Diagnostic performance of Siriraj gastrointesinal transit capsule

    5 days after intervention

Study Arms (1)

Experimental arm

EXPERIMENTAL

10 participants with chronic constipation according to Rome IV criteria and 10 healthy volunteers will receive 1 Sitzmark colonic capsule (contains 24 radiopaque markers) and 4 Siriraj gastrointestinal transit capsule (each contains 6 radiopaque markers).

Device: Siriraj gastrointestinal transit capsuleDevice: Sitz-Markers

Interventions

The Siriraj gastrointestinal transit capsule is a local made colonic transit capsule. Each capsule contains 6 circular-shaped radiopaque markers.

Also known as: Local made colonic capsule
Experimental arm

The standard Sitzmark colonic capsule containing 24 ring-shaped radiopaque markers.

Experimental arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteers with normal bowel habit not meet the criteria for functional constipation and irritable bowel syndrome with constipation according to Rome IV criteria
  • Participants with constipation according to Rome IV criteria

You may not qualify if:

  • Previous abdominal surgery
  • Participants at risk for intestinal obstruction such as endometriosis, history of intra-abdominal infection
  • Receive medication which affect colonic transit such as opioids
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine Siriraj Hospital, Mahidol University

Bangkoknoi, Bangkok, 10700, Thailand

Location

Related Publications (4)

  • Jaruvongvanich V, Patcharatrakul T, Gonlachanvit S. Prediction of Delayed Colonic Transit Using Bristol Stool Form and Stool Frequency in Eastern Constipated Patients: A Difference From the West. J Neurogastroenterol Motil. 2017 Oct 30;23(4):561-568. doi: 10.5056/jnm17022.

    PMID: 28738452BACKGROUND
  • Sharif H, Devadason D, Abrehart N, Stevenson R, Marciani L. Imaging Measurement of Whole Gut Transit Time in Paediatric and Adult Functional Gastrointestinal Disorders: A Systematic Review and Narrative Synthesis. Diagnostics (Basel). 2019 Dec 13;9(4):221. doi: 10.3390/diagnostics9040221.

    PMID: 31847098BACKGROUND
  • Bharucha AE, Anderson B, Bouchoucha M. More movement with evaluating colonic transit in humans. Neurogastroenterol Motil. 2019 Feb;31(2):e13541. doi: 10.1111/nmo.13541.

    PMID: 30681255BACKGROUND
  • Bharucha AE, Lacy BE. Mechanisms, Evaluation, and Management of Chronic Constipation. Gastroenterology. 2020 Apr;158(5):1232-1249.e3. doi: 10.1053/j.gastro.2019.12.034. Epub 2020 Jan 13.

    PMID: 31945360BACKGROUND

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 19, 2025

First Posted

February 27, 2025

Study Start

March 30, 2025

Primary Completion

May 30, 2025

Study Completion

May 30, 2025

Last Updated

September 30, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations